Maria Vistnes

658 total citations
26 papers, 466 citations indexed

About

Maria Vistnes is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Rheumatology. According to data from OpenAlex, Maria Vistnes has authored 26 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 5 papers in Epidemiology and 5 papers in Rheumatology. Recurrent topics in Maria Vistnes's work include Cardiac Fibrosis and Remodeling (7 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Maria Vistnes is often cited by papers focused on Cardiac Fibrosis and Remodeling (7 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Cardiac Valve Diseases and Treatments (3 papers). Maria Vistnes collaborates with scholars based in Norway, Sweden and Finland. Maria Vistnes's co-authors include Geir Christensen, Ivar Sjaastad, Ida G. Lunde, Cathrine R. Carlson, Torbjørn Omland, Anne Wæhre, Ståle Nygård, Cathrine Husberg, Helga Sanner and Thomas Schwartz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Maria Vistnes

25 papers receiving 456 citations

Peers

Maria Vistnes

CCM

EPIDE

RHEUM

PRM

Yuki Honda Japan

Fabiano Beraldi Calmasini Brazil

Wen Wen China

Nynke E. Hahn Netherlands

Piotr Szczepaniak Poland

Takahisa Tanikawa Japan

Aletta M. E. Millen South Africa

Toyohiko Yokoi Japan

Maria Grazia Zenti Italy

Xiaojuan Bai China

Yuki Honda Japan

Maria Vistnes

308 ×1.9

CCM

133 ×1.2

93 ×1.1

EPIDE

38 ×0.6

RHEUM

70 ×1.3

PRM

Citations per year, relative to Maria Vistnes Maria Vistnes (= 1×) peers Yuki Honda

Countries citing papers authored by Maria Vistnes

Since Specialization

Citations

This map shows the geographic impact of Maria Vistnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Vistnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Vistnes more than expected).

Fields of papers citing papers by Maria Vistnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Vistnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Vistnes. The network helps show where Maria Vistnes may publish in the future.

Co-authorship network of co-authors of Maria Vistnes

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Vistnes. A scholar is included among the top collaborators of Maria Vistnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Vistnes. Maria Vistnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vistnes, Maria, Tiina Ojala, Mats Synnergren, et al.. (2024). High‐sensitive troponinT, interleukin‐8, and interleukin‐6 link with post‐surgery risk in infant heart surgery. Acta Anaesthesiologica Scandinavica. 68(6). 745–752.

Vistnes, Maria. (2024). Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis. Pharmaceuticals. 17(3). 267–267. 10 indexed citations

Andersen, Geir Øystein, Pavel Hoffmann, Jan Eritsland, et al.. (2024). Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality. PLoS ONE. 19(5). e0302732–e0302732. 4 indexed citations

Englund, Martin, Maria Vistnes, Aleksandra Turkiewicz, et al.. (2024). BIOMARKERS FOR EROSIVE VS NON-EROSIVE HAND OSTEOARTHRITIS: THE NOR-HAND COHORT. Osteoarthritis and Cartilage. 32. S87–S87. 1 indexed citations

Romaine, Andreas, Pugazendhi M Erusappan, Arne Olav Melleby, et al.. (2023). Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development. SHILAP Revista de lepidopterología. 19-20. 100135–100135. 9 indexed citations

Neogi, Tuhina, S. Reza Jafarzadeh, Maria Vistnes, et al.. (2022). Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis. Arthritis & Rheumatology. 74(5). 810–817. 37 indexed citations

Robertsen, Ida, Marianne Kristiansen Kringen, Maria Vistnes, et al.. (2020). Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes. Journal of Pharmaceutical Sciences. 110(1). 432–437. 40 indexed citations

Vistnes, Maria, et al.. (2020). Obstructive sleep apnea versus central sleep apnea: prognosis in systolic heart failure. Cardiovascular Diagnosis and Therapy. 10(3). 396–404. 4 indexed citations

Sikkeland, Liv Ingunn Bjoner, et al.. (2019). Annual decline in forced expiratory volume and airway inflammatory cells and mediators in a general population-based sample. BMC Pulmonary Medicine. 19(1). 90–90. 3 indexed citations

10.

Suominen, Pertti, Håkan Wåhlander, Maria Vistnes, et al.. (2019). The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial*. Pediatric Critical Care Medicine. 20(10). 947–956. 16 indexed citations

11.

Syversen, Silje Watterdal, et al.. (2018). Associations between Cytokine Levels and CYP3A4 Phenotype in Patients with Rheumatoid Arthritis. Drug Metabolism and Disposition. 46(10). 1384–1389. 19 indexed citations

12.

Haugaa, Kristina H., et al.. (2016). A retrospective analysis of cardiovascular outcomes in patients treated with ASV. Scandinavian Cardiovascular Journal. 51(2). 106–113. 6 indexed citations

13.

Haugaa, Kristina H., et al.. (2014). ADAPTIVE SERVO-VENTILATION DECREASED MORTALITY AND ADMISSION RATES IN HEART FAILURE PATIENTS WITH CHEYNE-STOKES RESPIRATION IN A 18 MONTHS PROSPECTIVE STUDY. Journal of the American College of Cardiology. 63(12). A757–A757. 1 indexed citations

14.

Schwartz, Thomas, Ivar Sjaastad, Berit Flatø, et al.. (2014). In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction. Lara D. Veeken. 53(12). 2214–2222. 16 indexed citations

15.

Sanner, Helga, Thomas Schwartz, Berit Flatø, et al.. (2014). Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage. PLoS ONE. 9(3). e92171–e92171. 29 indexed citations

16.

Vistnes, Maria, Arne Høiseth, Helge Røsjø, et al.. (2013). Lack of pro-inflammatory cytokine mobilization predicts poor prognosis in patients with acute heart failure. Cytokine. 61(3). 962–969. 3 indexed citations

17.

Einvik, Gunnar, Maria Vistnes, Harald Hrubos‐Strøm, et al.. (2012). Circulating cytokine concentrations are not associated with major depressive disorder in a community-based cohort. General Hospital Psychiatry. 34(3). 262–267. 27 indexed citations

18.

Vistnes, Maria. (2012). Macrophage Inflammatory Protein-1β: A Novel Prognostic Biomarker in Atherosclerosis?. Cardiology. 121(3). 149–151. 7 indexed citations

19.

Vistnes, Maria, Geir Christensen, & Torbjørn Omland. (2010). Multiple cytokine biomarkers in heart failure. Expert Review of Molecular Diagnostics. 10(2). 147–157. 20 indexed citations

20.

Vistnes, Maria, Anne Wæhre, Ståle Nygård, et al.. (2010). Circulating cytokine levels in mice with heart failure are etiology dependent. Journal of Applied Physiology. 108(5). 1357–1364. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact